Results 261 to 270 of about 137,395 (319)

Exploring emerging psychopathological characteristics and challenges of novel depression subtypes: insights from the literature. [PDF]

Front Psychiatry
Chiappini S, Sampogna G, Ventriglio A, Menculini G, Ricci V, Pettorruso M, Volpe U, Martinotti G.   +7 more
europepmc   +1 more source

I'm Not the Doctor for You: Cognitive Bias, Complex Illness, and a Moral Imperative. [PDF]

Glob Adv Integr Med Health
Kuon CP.
europepmc   +1 more source

Cannabis and psychopathology: 2024 Snapshot of a meandering journey.

Indian J Psychiatry
Mahintamani T, Mukherjee D, Basu D.
europepmc   +1 more source

The Effect of Krocina™ on Decreasing Substance User Withdrawal Syndrome, Craving, Depression and Stress: A Double-Blind Randomized Parallel Clinical Trial

Substance Use & Misuse, 2022
Introduction Due to the association between substance use abstinence with some psychological syndromes, the use of herbal medicines such as Crocus sativus L. have been considered as a proper approach to controlling withdrawal syndrome.
Hamid Jomehpour, Shahrokh Aghayan, Ahmad Khosravi, Fahimeh Afzaljavan   +3 more
semanticscholar   +4 more sources

Pharmacological management of psychoactive substance withdrawal syndrome

Drugs & Therapy Perspectives, 2021
Medications are available to manage alcohol and drug withdrawal, but they are underutilized. Only a handful, such as methadone, buprenorphine, clonidine, or benzodiazepines (chlordiazepoxide, lorazepam, or diazepam), are prescribed. Our objective was to provide an adjusted, inclusive, critical review of the clinical benefits of medications studied for ...
Dimy Fluyau, Sarah Cook, Ashmeer Chima, Vasanth Kattalai Kailasam, Neelambika Revadigar   +4 more
semanticscholar   +4 more sources

Substance Withdrawal Syndrome

Definitions, 2020

semanticscholar   +3 more sources

[Delirium, catatonia and substance withdrawal syndrome manifested as psychomotor agitation in COVID-19: a pharmacological management approach for the general hospital setting].

Revista medica de Chile, 2022
BACKGROUND Neuropsychiatric symptoms can be part of the clinical spectrum of COVID-19 infections. AIM To devise an evidence based clinical algorithm as a guide for clinicians, to identify and treat underlying clinical syndromes of psychomotor agitation,
Felipe León, Constanza Caneo, Pablo Toro, J. Calderón, Matías González   +4 more
semanticscholar   +3 more sources

Substance Withdrawal Syndrome

, 2022

openalex   +2 more sources